CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
We have updated our Privacy Policy. Please review to learn more. By continuing to use our services, you agree to these updates. The nine-hour 4th of July airshow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results